TXNM Energy, Inc.
TXNM
$58.07
+0.38%
TXNM Energy, Inc. is a holding company that owns regulated utility companies providing electricity to homes and businesses across Texas and New Mexico. As a regulated electric utility operator, it benefits from stable, rate-base-driven revenue but faces capital-intensive infrastructure demands. The current investor narrative centers on the company's ability to manage rising interest expenses and regulatory outcomes, while its recent quarterly net loss and negative free cash flow have raised concerns about financial sustainability and the pace of its grid modernization investments.…
TXNM
TXNM Energy, Inc.
$58.07
Investment Opinion: Should I buy TXNM Today?
Rating: Hold. TXNM is a regulated utility with a reasonable forward P/E of 17.7x and revenue growth of 11.8% YoY, but persistent negative free cash flow and a Q4 net loss temper enthusiasm. The analyst consensus is moderately positive with an average target of $60.79 (5.9% upside), but the lack of a clear 'Buy' consensus indicates caution.
Supporting evidence: The forward P/E of 17.7x is below the 5-year average of ~22x, suggesting relative cheapness. Revenue grew 11.8% YoY to $533.2 million, outpacing typical utility growth. However, the trailing P/E of 36.1x is elevated due to depressed TTM earnings of $143.0 million, and free cash flow remains deeply negative at -$611.4 million TTM. The dividend yield of 2.98% provides some income, but the payout ratio of 108% indicates the dividend is not fully covered by earnings.
Risks & Conditions: The biggest risks are the inability to generate positive free cash flow and rising interest expenses ($125.8M in Q4). This Hold would upgrade to Buy if the company reports positive free cash flow and net income in the next two quarters, or if the forward P/E compresses below 15x. It would downgrade to Sell if revenue growth decelerates below 5% or if the dividend is cut. Valuation verdict: TXNM is fairly valued on a forward P/E basis but overvalued on a trailing basis relative to its own history.
Sign up to view all
TXNM 12-Month Price Forecast
TXNM's investment case is balanced: the stock offers a reasonable forward valuation and above-average revenue growth, but persistent negative free cash flow and a recent net loss raise red flags. The neutral stance reflects the tension between cheap valuation and weak financial health. If the company can demonstrate progress toward positive free cash flow and consistent profitability, the stance would upgrade to bullish. Conversely, if interest expenses continue to rise or regulatory outcomes disappoint, a bearish stance would be warranted.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TXNM Energy, Inc.'s 12-month outlook, with a consensus price target around $60.70 and implied upside of +4.5% versus the current price.
Average Target
$60.70
0 analysts
Implied Upside
+4.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$59 - $61
Analyst target range
TXNM is covered by 6 analysts, with a consensus recommendation leaning bullish (mix of Overweight, Outperform, and Sector Perform ratings). The average target price is $60.79, implying 5.9% upside from the current price of $57.41. The consensus is moderately positive, but the lack of a clear 'Buy' consensus (recommendation field shows 'none') indicates some caution. The target range spans from $59.00 (low) to $61.25 (high), a spread of $2.25 or 3.9% of the average target, reflecting relatively high conviction among analysts. The high target of $61.25 assumes successful execution on rate cases and cost management, while the low target of $59.00 prices in regulatory headwinds or higher interest costs. Recent ratings actions include Jefferies downgrading from Buy to Hold in October 2025, while Mizuho upgraded from Neutral to Outperform in March 2025, and Evercore ISI upgraded from In Line to Outperform in February 2025. The mixed revisions suggest uncertainty about the near-term outlook.
Bulls vs Bears: TXNM Investment Factors
TXNM presents a mixed picture: the bull case rests on a reasonable forward P/E of 17.7x, accelerating revenue growth of 11.8% YoY, and a defensive beta of 0.173, supported by analyst targets implying 5.9% upside. However, the bear case is substantial, with persistent negative free cash flow (-$611.4M TTM), a Q4 net loss, poor liquidity (current ratio 0.19), and rising interest expenses that have more than doubled. The single most important tension is whether the company can translate its revenue growth into sustainable profitability and positive free cash flow, or if the heavy capital expenditure burden and debt costs will continue to depress earnings. Currently, the bearish evidence on financial health outweighs the valuation appeal, making the stock a Hold rather than a Buy.
Bullish
- Forward P/E Below Historical Average: TXNM's forward P/E of 17.7x is below its 5-year average of ~22x, suggesting the stock is relatively cheap on a forward earnings basis. This implies the market is pricing in a recovery from the recent loss quarter, and if earnings materialize, the stock could re-rate higher.
- Revenue Growth Accelerating YoY: Revenue grew 11.8% year-over-year to $533.2 million in Q4 2025, driven by the Electricity segment. This growth outpaces the typical utility sector growth rate of 3-5%, indicating strong demand in its service territories.
- Analyst Consensus with 5.9% Upside: The average analyst target price is $60.79, implying 5.9% upside from the current price of $57.41. With 6 analysts covering and a target range of $59.00-$61.25, the consensus is moderately positive.
- Low Beta Provides Defensive Stability: With a beta of 0.173, TXNM is significantly less volatile than the market, making it a defensive holding. This low correlation to market swings can protect capital during downturns and provides stable, regulated returns.
Bearish
- Negative Free Cash Flow Persists: TXNM has reported negative free cash flow for at least eight consecutive quarters, with Q4 2025 FCF of -$152.1 million and TTM FCF of -$611.4 million. This indicates the company is heavily reliant on external financing to fund capital expenditures, raising sustainability concerns.
- Q4 Net Loss Swings to Red: The company reported a net loss of -$9.7 million in Q4 2025, compared to net income of $15.8 million in Q4 2024. The net margin turned negative at -1.8%, driven by elevated interest expenses of $125.8 million.
- Poor Liquidity and High Debt Burden: The current ratio of 0.19 indicates severe liquidity constraints, meaning current assets cover only 19% of current liabilities. Despite a low debt-to-equity ratio (0.00076), the debt ratio of 0.50 shows significant leverage, and interest expenses have grown 114% YoY to $125.8 million.
- Underperformance vs. Market Over 3 Months: TXNM has underperformed the S&P 500 by -7.32% over the past 3 months, with a 3-month price change of -2.65% versus SPY's +4.67%. This relative weakness suggests fading momentum and potential investor concerns.
TXNM Technical Analysis
TXNM is trading in a range-bound consolidation pattern near the top of its 52-week range, with a 1-year price change of +1.29% and the current price at 96.5% of the 52-week range (55.64–59.53). This positioning near highs suggests mild momentum but limited upside potential without a catalyst, as the stock has failed to break above resistance. Short-term momentum shows divergence: the 1-month change is +1.70%, while the 3-month change is -2.65%, indicating a recent pullback from higher levels. The 1-month relative strength of 1.39 versus SPY's 0.31% suggests outperformance in the near term, but the 3-month relative strength of -7.32% signals underlying weakness compared to the broader market. The 52-week low of $55.64 provides support, while the 52-week high of $59.53 is resistance. A breakout above $59.53 would signal a resumption of the uptrend, while a breakdown below $55.64 could accelerate selling. With a beta of 0.173, TXNM is significantly less volatile than the market, making it a defensive holding but limiting upside participation in rallies.
Beta
0.17
0.17x market volatility
Max Drawdown
-5.2%
Largest decline past year
52-Week Range
$56-$60
Price range past year
Annual Return
+2.3%
Cumulative gain past year
| Period | TXNM Return | S&P 500 |
|---|---|---|
| 1m | +0.8% | +1.0% |
| 3m | -2.0% | +1.1% |
| 6m | -1.4% | +13.8% |
| 1y | +2.3% | +19.5% |
| ytd | -1.7% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TXNM Fundamental Analysis
Revenue grew 11.8% year-over-year to $533.2 million in Q4 2025, driven by the Electricity segment ($533.2M) and Electric Transmission Service ($86.0M). However, the quarterly revenue trend shows volatility: Q3 2025 revenue was $647.2M, Q2 $502.4M, and Q1 $482.8M, indicating seasonal fluctuations rather than consistent acceleration. The company reported a net loss of -$9.7 million in Q4 2025, compared to net income of $15.8 million in Q4 2024, swinging to a loss. Gross margin compressed to 35.6% in Q4 2025 from 34.9% in Q4 2024, while operating margin fell to 17.6% from 15.6% in the prior year quarter. The net margin turned negative at -1.8%, reflecting elevated interest expenses ($125.8M) and other costs. The company is not consistently profitable, with trailing twelve-month net income of $143.0M but negative free cash flow of -$611.4M. Free cash flow has been negative for at least the past eight quarters, with Q4 2025 FCF of -$152.1M. The debt-to-equity ratio is very low at 0.00076, but this is misleading due to high debt levels (debt ratio of 0.50). The current ratio of 0.19 indicates poor liquidity, and the company relies on external financing (debt and equity issuance) to fund capital expenditures, as seen in Q2 2025 common stock issuance of $645.3M.
Quarterly Revenue
$533232000.0B
2025-12
Revenue YoY Growth
+11.8%
YoY Comparison
Gross Margin
35.6%
Latest Quarter
Free Cash Flow
$-611432999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TXNM Overvalued?
Since net income is positive on a trailing twelve-month basis (TTM net income of $143.0M), the primary valuation metric is the P/E ratio. The trailing P/E is 36.1x, while the forward P/E is 17.7x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E suggests that the market is pricing in a recovery from the recent loss quarter. Compared to the industry average (not provided, but regulated utilities typically trade at 15-20x forward earnings), TXNM's forward P/E of 17.7x appears in line with the sector. However, the trailing P/E of 36.1x is elevated due to depressed earnings. The price-to-sales ratio of 2.53x is below the industry average of 3.0x (estimated), indicating a discount on a sales basis. Historically, TXNM's trailing P/E has ranged from 7.5x (Q3 2024) to 137.3x (Q1 2025), and the current 36.1x is near the middle of that range. The forward P/E of 17.7x is below the 5-year average of ~22x, suggesting the stock is relatively cheap on a forward basis if earnings materialize.
PE
39.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~71x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: TXNM's most pressing financial risk is its persistent negative free cash flow, which has been negative for eight consecutive quarters, totaling -$611.4 million over the trailing twelve months. This forces reliance on external financing, as evidenced by the $645.3 million common stock issuance in Q2 2025. The company's net loss of -$9.7 million in Q4 2025 and negative net margin of -1.8% highlight earnings fragility, while interest expenses have surged 114% year-over-year to $125.8 million, consuming a significant portion of operating income. The current ratio of 0.19 indicates acute liquidity risk, meaning the company may struggle to meet short-term obligations without additional capital markets access.
Market & Competitive Risks: As a regulated utility, TXNM faces regulatory risk from rate case outcomes in Texas and New Mexico, which could limit allowed returns or delay cost recovery. The stock's low beta of 0.173 limits upside participation in market rallies, and its 3-month relative underperformance of -7.32% versus the S&P 500 suggests waning investor confidence. Valuation risk is moderate: the trailing P/E of 36.1x is elevated due to depressed earnings, but the forward P/E of 17.7x is in line with utility peers. However, if interest rates remain high, the stock could face multiple compression as investors demand higher yields from defensive equities.
Worst-Case Scenario: In a severe downturn, TXNM could face a regulatory disallowance on capital investments, further earnings deterioration from rising interest costs, and a credit rating downgrade that increases borrowing costs. The stock could fall to its 52-week low of $55.64, representing a -3.1% decline from the current price of $57.41. However, given the regulated nature and low beta, the realistic downside is limited; the maximum drawdown over the past year was -5.18%, suggesting a worst-case loss of approximately -5% to -10% from current levels.
FAQ
The primary risk is financial: negative free cash flow of -$611.4 million TTM and a current ratio of 0.19 indicate potential liquidity issues and reliance on external financing. Second, interest expense risk: Q4 interest expenses of $125.8 million have more than doubled year-over-year, pressuring earnings. Third, regulatory risk: adverse rate case outcomes in Texas or New Mexico could limit allowed returns. Fourth, macro risk: while beta is low at 0.173, rising interest rates could compress utility valuations. The most severe risk is a dividend cut if cash flow does not improve, given the payout ratio of 108%.
The 12-month outlook is mixed. The base case (50% probability) sees the stock trading between $57 and $60, with revenue growth of 8-10% but continued negative free cash flow. The bull case (25% probability) targets $60-$61.25, driven by favorable rate cases and Fed rate cuts. The bear case (25% probability) sees the stock falling to $55-$57 if regulatory or interest cost headwinds intensify. The most likely scenario is the base case, where the stock remains range-bound near current levels, with the key assumption that the company can maintain revenue growth while managing costs.
On a forward P/E basis, TXNM appears undervalued at 17.7x, below its 5-year average of ~22x and in line with the utility sector average of 15-20x. However, the trailing P/E of 36.1x is elevated due to depressed trailing earnings, which include a net loss quarter. The price-to-sales ratio of 2.53x is below the estimated industry average of 3.0x, suggesting a discount on sales. Overall, the stock is fairly valued on forward earnings but overvalued on trailing earnings, reflecting the market's expectation of a recovery. The valuation implies investors are pricing in a return to normalized profitability.
TXNM is a hold rather than a buy at current levels. The stock offers a forward P/E of 17.7x, below its historical average, and analyst targets imply 5.9% upside to $60.79. However, the company's negative free cash flow of -$611.4 million TTM and a Q4 net loss of -$9.7 million are significant concerns. For risk-tolerant investors with a long-term horizon, the cheap valuation and defensive beta (0.173) may be appealing, but those seeking stable earnings and dividends should wait for evidence of financial improvement. The biggest downside risk is a dividend cut if cash flow does not improve.
TXNM is better suited for long-term investment due to its low beta (0.173), regulated business model, and dividend yield of 2.98%. Short-term trading is less attractive given the stock's low volatility and narrow trading range near the 52-week high. The company's negative free cash flow and earnings volatility make it a hold for long-term investors who can wait for a turnaround. A minimum holding period of 2-3 years is recommended to allow for regulatory outcomes and capital investment benefits to materialize. For short-term traders, the lack of catalysts and low beta limit profit potential.